Mereo BioPharma Group plc (MREO) - 13D/13G Filings

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1, 2, 3, Next
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2024-02-14
6:51 pm
Sale
2023-12-3113GMereo BioPharma Group plc
MREO
ORBIMED ADVISORS LLC0
0.000%
-10,378,591decrease
(Position Closed)
Filing
History
2024-02-14
2:11 pm
Unchanged
2023-12-3113GMereo BioPharma Group plc
MREO
Rock Springs Capital Management LP39,919,255
5.690%
0
(Unchanged)
Filing
History
2024-02-14
2:10 pm
Purchase
2023-07-0313GMereo BioPharma Group plc
MREO
Rock Springs Capital Management LP39,919,255
6.380%
8,694,770increase
(+27.85%)
Filing
History
2024-02-14
12:36 pm
Purchase
2023-12-3113GMereo BioPharma Group plc
MREO
Mangrove Partners IM, LLC43,764,465
6.240%
43,764,465increase
(New Position)
Filing
History
2024-02-13
5:26 pm
Purchase
2023-12-3113GMereo BioPharma Group plc
MREO
SUVRETTA CAPITAL MANAGEMENT LLC36,854,190
5.300%
32,000increase
(+0.09%)
Filing
History
2024-02-06
4:15 pm
Purchase
2023-12-3113GMereo BioPharma Group plc
MREO
Soleus Private Equity Fund III, L.P.48,887,095
7.000%
500,000increase
(+1.03%)
Filing
History
2024-02-05
5:09 pm
Purchase
2024-01-2413GMereo BioPharma Group plc
MREO
ADAGE CAPITAL PARTNERS GP L.L.C.50,250,000
7.170%
50,250,000increase
(New Position)
Filing
History
2023-11-20
08:45 am
Purchase
2023-11-1613DMereo BioPharma Group plc
MREO
Rubric Capital Management LP99,704,885
14.220%
2,378,330increase
(+2.44%)
Filing
History
2023-11-15
07:56 am
Purchase
2023-11-1313DMereo BioPharma Group plc
MREO
Rubric Capital Management LP97,326,555
13.880%
7,200increase
(+0.01%)
Filing
History
2023-11-13
07:31 am
Purchase
2023-11-0913DMereo BioPharma Group plc
MREO
Rubric Capital Management LP97,319,355
13.880%
1,758,195increase
(+1.84%)
Filing
History
2023-11-08
07:06 am
Purchase
2023-11-0613DMereo BioPharma Group plc
MREO
Rubric Capital Management LP95,561,160
13.630%
2,188,575increase
(+2.34%)
Filing
History
2023-11-06
07:30 am
Purchase
2023-11-0313DMereo BioPharma Group plc
MREO
Rubric Capital Management LP93,372,585
13.320%
1,081,380increase
(+1.17%)
Filing
History
2023-11-02
07:30 am
Purchase
2023-10-3113DMereo BioPharma Group plc
MREO
Rubric Capital Management LP92,291,205
13.250%
92,130increase
(+0.10%)
Filing
History
2023-10-30
6:02 pm
Purchase
2023-10-2713DMereo BioPharma Group plc
MREO
Rubric Capital Management LP92,199,075
13.150%
2,168,475increase
(+2.41%)
Filing
History
2023-08-10
4:42 pm
Sale
2023-07-3113GMereo BioPharma Group plc
MREO
Baker Bros. Advisors LP14,604,391
2.200%
-54,754,968decrease
(-78.94%)
Filing
History
2023-07-26
4:31 pm
Purchase
2023-07-2413GMereo BioPharma Group plc
MREO
Soleus Private Equity Fund III, L.P.48,387,095
7.500%
48,387,095increase
(New Position)
Filing
History
2023-06-16
08:00 am
Purchase
2023-06-1413DMereo BioPharma Group plc
MREO
Rubric Capital Management LP90,030,600
14.410%
6,250,000increase
(+7.46%)
Filing
History
2023-02-14
4:40 pm
Purchase
2022-12-3113GMereo BioPharma Group plc
MREO
ORBIMED ADVISORS LLC10,378,591
5.920%
4,315,246increase
(+71.17%)
Filing
History
2023-02-14
4:03 pm
Sale
2022-12-3113GMereo BioPharma Group plc
MREO
Point72 Asset Management, L.P.22
0.100%
-10,609,978decrease
(-100.00%)
Filing
History
2023-02-14
4:00 pm
Purchase
2022-12-3113GMereo BioPharma Group plc
MREO
Baker Bros. Advisors LP69,359,359
9.990%
4,441,758increase
(+6.84%)
Filing
History
Goto Prev, 0, 1, 2, 3, Next